73 related articles for article (PubMed ID: 2949757)
1. Desogestrel-containing oral contraceptives and blood pressure.
Dieben TO; van Beek A
Arzneimittelforschung; 1986 Nov; 36(11):1678-80. PubMed ID: 2949757
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.
Bilotta P; Favilli S
Arzneimittelforschung; 1988 Jul; 38(7):932-4. PubMed ID: 2974702
[TBL] [Abstract][Full Text] [Related]
4. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
5. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
6. Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
Rákóczi I; Gerö G; Demeter J; Gáti I
Arzneimittelforschung; 1985; 35(3):630-3. PubMed ID: 3158320
[TBL] [Abstract][Full Text] [Related]
7. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
Weijers MJ
Clin Ther; 1982; 4(5):359-66. PubMed ID: 6461412
[TBL] [Abstract][Full Text] [Related]
9. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Meurer LN; Slawson JG
J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
[No Abstract] [Full Text] [Related]
10. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Coenen CM; Thomas CM; Borm GF; Rolland R
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
[TBL] [Abstract][Full Text] [Related]
11. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
Weijers MJ
Fortschr Med; 1982 Apr; 100(16):764-7. PubMed ID: 6211403
[TBL] [Abstract][Full Text] [Related]
12. Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene.
Rechberger T; Tomaszewski J; Pieprzowska-Białek A; Kulik-Rechberger B; Skorupski P
Contraception; 2004 Jun; 69(6):477-80. PubMed ID: 15157792
[TBL] [Abstract][Full Text] [Related]
13. [Hormonal contraception with marvelon. Experiences with marvelon in gynecologic practice--a multicenter study by 265 gynecologists on over 26,000 women].
Geissler KH
Fortschr Med; 1983 Jun; 101(22):1060-4. PubMed ID: 6223870
[No Abstract] [Full Text] [Related]
14. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
Jick SS; Jick H
Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227
[TBL] [Abstract][Full Text] [Related]
15. [The combined effect of an ethinylestradiol/desogestrel contraceptive combination on blood lipids and parameters of liver function and coagulation].
Massafra C; Capitani S; Bernabei A; Scillone L
Rev Fr Gynecol Obstet; 1988 Apr; 83(4):251-5. PubMed ID: 2969134
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal contraceptives and arterial hypertension].
Janaszek-Sitkowska H
Pol Tyg Lek; 1984 Oct 1-8; 39(40-41):1341-3. PubMed ID: 6393087
[TBL] [Abstract][Full Text] [Related]
17. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
[TBL] [Abstract][Full Text] [Related]
18. Desogestrel, a new progestational compound, and the liver.
Weijers MJ
Arzneimittelforschung; 1983; 33(5):774-6. PubMed ID: 6223646
[TBL] [Abstract][Full Text] [Related]
19. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
[No Abstract] [Full Text] [Related]
20. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
